siRNA, Anti-ACTC1, 2'-OMe/LNA/Ribo/Backbone-modified(CAT#: SIRGT01044WQ-2OMe)

The product SIRGT01044WQ-2OMe is a type of small interfering RNA (siRNA) that targets ACTC1 gene and regulates the expression of gene. The siRNA interferes with the expression of ACTC1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_005159.4
Alternative Names ACTC; ASD5; CMD1R; CMH11; LVNC4
Related Diseases Atrial Septal Defect 5, Cardiomyopathy
Purification HPLC
Target Gene
Gene ID 70
Uniprot ID P68032
Sub Cat Target Species Modification Scale  
SIRGT04044WQ-LNA ACTC1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01044WQ-RB ACTC1 Human Ribo-modified Inquiry
SIRGT02044WQ-BB ACTC1 Human Backbone-modified Inquiry

Related Products